ID   F4/B8
AC   CVCL_9R59
SY   B8
DR   Wikidata; Q54833136
RX   PubMed=1057176;
RX   PubMed=4514957;
CC   Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21895; Mouse erythroid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9R58 ! FSD1/F4
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 5
//
RX   PubMed=1057176; DOI=10.1073/pnas.72.5.1863; PMCID=PMC432647;
RA   Dube S.K., Pragnell I.B., Kluge N., Gaedicke G., Steinheider G.,
RA   Ostertag W.;
RT   "Induction of endogenous and of spleen focus-forming viruses during
RT   dimethylsulfoxide-induced differentiation of mouse erythroleukemia
RT   cells transformed by spleen focus-forming virus.";
RL   Proc. Natl. Acad. Sci. U.S.A. 72:1863-1867(1975).
//
RX   PubMed=4514957; DOI=10.1038/newbio243203a0;
RA   Ostertag W., Crozier T.A., Kluge N., Melderis H., Dube S.K.;
RT   "Action of 5-bromodeoxyuridine on the induction of haemoglobin
RT   synthesis in mouse leukaemia cells resistant to 5-BUdR.";
RL   Nat. New Biol. 243:203-205(1973).
//